As mobilisation for phase 3 of the Covid-19 vaccination booster programme accelerates, the CCG’s TNW Medicines Optimisation team is providing support through webinars and Q&A sessions.
In phase 3 with 9 more Local Vaccination sites being established, there will need to be more involvement of the PCN and practice pharmacists in both the service delivery, e.g. reconstitution of vaccine, and operational assurance of the sites, although the CCG pharmacist leads will still have professional responsibility for the overall assurance. We have also been in touch with the PCN Clinical Directors.
The TNW Medicines Optimisation team would like to invite all Primary Care Network Pharmacists, Practice Pharmacists and GP Federation Pharmacists in Tower Hamlets, Newham and Waltham Forest to attend this 2 part training webinar.
- The sessions will be 60 minutes each, approx. 40 minutes of slides with a Q&A session.
- Each session will be different as there is a lot of information to cover, but they will be recorded and made available afterwards for any staff unable to attend.
- Although the CCG’s MO team will always endeavour to answer individual queries, given the simultaneous mobilisation of a number of new sites and our very limited capacity, we are requesting that PCNs all make use of sessions outlined above and try to keep individual questions outside of the sessions to a minimum if at all possible.
- Utilise the main sources of information relating to the vaccine programme
- Understand how assurance of the vaccine programme operates and how this differs from other services commissioned from GP practices
- Understand the main aspects of cold chain management of the vaccines and the requirements of all sites. The session will include examples of cold chain excursions
- Understand the differences between the legal frameworks that vaccine sites can use to enable them to administer the vaccine
- Understand the MHRA licensing arrangements and the responsibilities these give to pharmacists and other registered healthcare professionals. A key issue covered here will be the movement of vaccine.
- Understand the main operational implications of the 3 different types of vaccine currently available in the UK
- Outline the key aspects of phase 3 that are still unclear and how this affects the mobilisation of the sites
- Outline the main risks relating to operating vaccine sites and how these might be mitigated
- Understand their roles and responsibilities in implementing the programme
TNW Medicines Optimisation Team